hydralazine has been researched along with Ductus Arteriosus, Patent in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Ductus Arteriosus, Patent: A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gavaghan, BJ | 1 |
| Lapointe, JM | 1 |
| Thomas, WP | 1 |
1 other study available for hydralazine and Ductus Arteriosus, Patent
| Article | Year |
|---|---|
Acute onset of pulmonary necrotising arteritis in a dog with a left-to-right patent ductus arteriosus.
Topics: Acute Disease; Animals; Antihypertensive Agents; Dog Diseases; Dogs; Ductus Arteriosus, Patent; Echo | 1998 |